Arcutis Biotherapeutics Inc (ARQT)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ARQT? Forum Prognose

Finanzdaten der Arcutis Biotherapeutics Inc-Aktie (ARQT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	30.52% 129.50	99.22	81.50	65.85	71.36
Cost Of Revenue	34.58% 11.69	8.685	7.492	8.83	6.905
Gross Profit	30.13% 117.81	90.53	74.01	57.02	64.45
Operating Expenses	21.24% 99.43	82.01	88.62	81.55	72.09
Benefits Costs and Expenses	22.52% 111.12	90.69	96.11	90.38	78.99
Costs And Expenses	22.52% 111.12	90.69	96.11	90.38	78.99
Operating Income/Loss	115.66% 18.39	8.526	-14.61	-24.53	-7.632
Income/Loss From Continuing Operations Before Tax	115.66% 18.39	8.526	-15.89	-25.06	-7.632
Income Tax Expense/Benefit	487.50% 0.47	0.08	0.342	0.279	0.323
Income/Loss From Continuing Operations After Tax	134.75% 17.39	7.41	-15.89	-25.06	-10.79
Net Income/Loss	134.75% 17.39	7.41	-15.89	-25.06	-10.79
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.73% 0.343	127.62	127.00	126.04	1.3299
Diluted Average Shares	99.74% 0.343	132.88	127.00	126.04	1.3299
Basic Earnings Per Share	116.67% 0.13	0.06	-0.13	-0.20	-0.08
Diluted Earnings Per Share	116.67% 0.13	0.06	-0.13	-0.20	-0.08
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%